FME Stock Financial Analysis - Fresenius Medical Care AG (BRSE) Stock

Overview

Fresenius Medical Care AG, headquartered in Germany, is a leading global healthcare group specializing in dialysis services and products for individuals with renal diseases. As the world’s largest provider of dialysis products and services, the company operates numerous clinics worldwide, offering dialysis treatments and related laboratory services directly to patients. Additionally, Fresenius Medical Care is a prominent manufacturer of dialysis equipment and disposables, including dialyzers and dialysis machines, contributing significantly to the technological advancements in the treatment of chronic kidney failure. The company's ongoing projects often focus on innovation in renal therapies, improving treatment efficacy and patient outcomes, and expanding their global network to provide access to dialysis services in underserved regions.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Fresenius Medical Care AG as of 30 June 2025 is 19,518.12 MM.
The operating income for Fresenius Medical Care AG as of 30 June 2025 is 1,580.57 MM.
The net income for Fresenius Medical Care AG as of 30 June 2025 is 656.42 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	19,518.12	1,580.57	656.42
2025-03-31	19,492.84	1,559.62	618.17
2024-12-31	19,335.91	1,539.37	537.91
2024-09-30	19,239.01	1,626.14	658.94
2024-06-30	19,415.08	1,594.70	530.26
2024-03-31	19,473.92	1,578.29	483.59
2023-12-31	19,453.62	1,523.56	499.00
2023-09-30	19,462.53	1,414.23	449.88
2023-06-30	19,622.46	1,537.49	595.62
2023-03-31	19,553.87	1,515.49	602.41
2022-12-31	19,398.02	1,537.95	673.40
2022-09-30	19,048.24	1,665.89	763.34
2022-06-30	18,393.44	1,661.81	806.29
2022-03-31	17,956.93	1,728.57	877.72
2021-12-31	17,618.69	1,903.83	969.31
2021-09-30	17,371.81	1,917.09	917.75
2021-06-30	17,344.22	2,041.07	998.21
2021-03-31	17,581.39	2,291.29	1,130.60
2020-12-31	17,859.06	2,377.71	1,164.38
2020-09-30	18,038.87	2,436.25	1,329.70

Income Statement: EPS

The earnings per share basic for Fresenius Medical Care AG as of 30 June 2025 is 2.24.
The earnings per share diluted for Fresenius Medical Care AG as of 30 June 2025 is 2.23.

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30	2.24	2.23
2025-03-31	2.11	2.11
2024-12-31	1.83	1.83
2024-09-30	2.25	2.25
2024-06-30	1.81	1.81
2024-03-31	1.65	1.65
2023-12-31	1.70	1.70
2023-09-30	1.53	1.54
2023-06-30	2.03	2.03
2023-03-31	2.05	2.05
2022-12-31	2.30	2.30
2022-09-30	2.60	2.60
2022-06-30	2.75	2.75
2022-03-31	3.00	3.00
2021-12-31	3.31	3.31
2021-09-30	3.13	3.14
2021-06-30	3.41	3.42
2021-03-31	3.86	3.86
2020-12-31	3.96	3.96
2020-09-30	4.50	4.49

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Fresenius Medical Care AG as of 30 June 2025 is 2,754.17 MM.
The cash from investing activities for Fresenius Medical Care AG as of 30 June 2025 is -589.42 MM.
The cash from financing activities for Fresenius Medical Care AG as of 30 June 2025 is -1,501.84 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	2,754.17	-589.42	-1,501.84
2025-03-31	2,421.66	-124.81	-2,418.43
2024-12-31	2,386.14	-84.94	-2,569.30
2024-09-30	2,273.51	-62.25	-2,349.77
2024-06-30	2,048.55	6.58	-2,285.01
2024-03-31	2,613.27	-449.32	-2,150.20
2023-12-31	2,628.80	-544.23	-1,858.53
2023-09-30	2,509.39	-672.67	-1,232.79
2023-06-30	2,407.25	-622.36	-1,322.99
2023-03-31	2,151.52	-686.69	-1,348.70
2022-12-31	2,167.38	-734.73	-1,617.36
2022-09-30	2,236.77	-932.57	-1,854.98
2022-06-30	2,270.84	-1,132.04	-1,640.97
2022-03-31	2,440.55	-1,183.49	-1,255.11
2021-12-31	2,489.50	-1,196.23	-1,024.38
2021-09-30	2,404.64	-1,227.79	-1,235.44
2021-06-30	2,458.61	-1,215.20	-1,640.05
2021-03-31	3,856.74	-1,246.66	-2,468.41
2020-12-31	4,233.16	-1,334.94	-2,664.03
2020-09-30	4,419.68	-1,421.39	-2,259.78

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30

Management Effectiveness

The roa for Fresenius Medical Care AG as of 30 June 2025 is 0.02.
The roe for Fresenius Medical Care AG as of 30 June 2025 is 0.04.
The roic for Fresenius Medical Care AG as of 30 June 2025 is 0.02.
The croic for Fresenius Medical Care AG as of 30 June 2025 is -0.00.
The ocroic for Fresenius Medical Care AG as of 30 June 2025 is 0.09.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.02	0.04	0.02	-0.00	0.09
2025-03-31	0.02	0.04	0.02	-0.01	0.09
2024-12-31	0.02	0.04	0.03	-0.01	0.09
2024-09-30	0.01	0.04	0.02	-0.01	0.08
2024-06-30	0.01	0.03	0.02	-0.00	0.10
2024-03-31	0.01	0.03	0.02	0.01	0.10
2023-12-31	0.01	0.03	0.02	0.02	0.09
2023-09-30	0.02	0.04	0.02	0.01	0.09
2023-06-30	0.02	0.04	0.02	0.01	0.09
2023-03-31	0.02	0.04	0.02	0.00	0.08
2022-12-31	0.02	0.05	0.02	-0.01	0.08
2022-09-30	0.02	0.06	0.02	-0.01	0.07
2022-06-30	0.02	0.06	0.03	-0.01	0.08
2022-03-31	0.03	0.07	0.03	0.00	0.09
2021-12-31	0.03	0.08	0.04	0.01	0.09
2021-09-30	0.03	0.07	0.03	-0.00	0.09
2021-06-30	0.03	0.07	0.04	-0.02	0.09
2021-03-31	0.03	0.09	0.04	0.00	0.15
2020-12-31	0.04	0.09	0.05	0.00	0.17
2020-09-30	0.04	0.10	0.05	0.02	0.17

Gross Margins

The gross margin for Fresenius Medical Care AG as of 30 June 2025 is 0.24.
The net margin for Fresenius Medical Care AG as of 30 June 2025 is 0.03.
The operating margin for Fresenius Medical Care AG as of 30 June 2025 is 0.09.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.24	0.03	0.09
2025-03-31	0.25	0.03	0.07
2024-12-31	0.25	0.03	0.09
2024-09-30	0.25	0.03	0.09
2024-06-30	0.25	0.02	0.08
2024-03-31	0.25	0.03	0.06
2023-12-31	0.27	0.02	0.07
2023-09-30	0.27	0.03	0.08
2023-06-30	0.27	0.03	0.08
2023-03-31	0.27	0.03	0.08
2022-12-31	0.27	0.03	0.07
2022-09-30	0.28	0.04	0.08
2022-06-30	0.28	0.04	0.09
2022-03-31	0.29	0.05	0.10
2021-12-31	0.29	0.06	0.10
2021-09-30	0.30	0.05	0.11
2021-06-30	0.30	0.06	0.12
2021-03-31	0.30	0.06	0.13
2020-12-31	0.31	0.07	0.13
2020-09-30	0.31	0.07	0.13

GB:FMED
GB:0H9X	€ 42,00
AT:FME
DE:FME	€ 41,95
BG:FME
IT:1FME	€ 41,50
US:FMCQF